HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$2.02
Day range
$1.96 - $2.03
Year range
$1.40 - $18.00
Market cap
5.72M USD
Avg Volume
2.87M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.81M | -31.57% |
Net income | -2.73M | 32.21% |
Net profit margin | — | — |
Earnings per share | -1.11 | 69.17% |
EBITDA | -2.81M | 28.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.92M | -16.96% |
Total assets | 9.94M | -20.01% |
Total liabilities | 1.06M | -53.66% |
Total equity | 8.88M | — |
Shares outstanding | 2.86M | — |
Price to book | 0.65 | — |
Return on assets | -89.30% | — |
Return on capital | -99.18% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.73M | 32.21% |
Cash from operations | -2.05M | 3.08% |
Cash from investing | — | — |
Cash from financing | 6.26M | -1.40% |
Net change in cash | 4.21M | -0.56% |
Free cash flow | -1.44M | -117.88% |
About
Founded
2011
Headquarters
Website
Employees
13